Free Trial
FRA:FRE

Fresenius SE & Co. KGaA (FRE) Stock Price, News & Analysis

Fresenius SE & Co. KGaA logo
€42.38 -0.16 (-0.38%)
As of 05/29/2025

About Fresenius SE & Co. KGaA Stock (FRA:FRE)

Key Stats

Today's Range
€42.23
€42.79
50-Day Range
€35.17
€44.03
52-Week Range
€60.16
€80.00
Volume
498,052 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, dialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients. This segment offers I.V. generic drugs; biosimilar drugs for autoimmune diseases and oncology; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The Fresenius Vamed segment provides services for hospitals and other healthcare facilities. This segment also offers operational management of healthcare facilities and provides services to patients. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.

Receive FRE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fresenius SE & Co. KGaA and its competitors with MarketBeat's FREE daily newsletter.

FRE Stock News Headlines

Trump wipes out trillions overnight…
Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out nearly $5 trillion in wealth from the S&P 500 and $6.4 trillion from the Dow Jones… Not to mention the countless trillions of dollars lost in every market around the world… leaving the major political powers scrambling in fear of Trump’s next move.
Fresenius SE & Co. KGaA (0OO9) Gets a Buy from Deutsche Bank
See More Headlines

FRE Stock Analysis - Frequently Asked Questions

Fresenius SE & Co. KGaA's stock was trading at €33.48 on January 1st, 2025. Since then, FRE stock has increased by 26.6% and is now trading at €42.38.
View the best growth stocks for 2025 here
.

Based on aggregate information from My MarketBeat watchlists, some other companies that Fresenius SE & Co. KGaA investors own include Illumina (ILMN), Daimler (DAI), Endologix (ELGX), APA (APA), Cambrex (CBM), Micron Technology (MU) and Bayer Aktiengesellschaft (BAYN).

Industry, Sector and Symbol

Stock Exchange
FRA
Sector
Medical
Industry
Medical Care Facilities
Sub-Industry
Medical Equipment
Current Symbol
FRA:FRE
CIK
N/A
Fax
N/A
Employees
190,863
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (FRA:FRE) was last updated on 5/30/2025 by MarketBeat.com Staff
From Our Partners